Amarin Corp Plc (AMRN)

[Whalatane]

Capt. They are already doing studies in CAD patients undergoing repeat revascularisation in the EU . Here is a 12 mth study on blood thinners ( I think )
https://academic.oup.com/eurheartj/article/44/Supplement_2/ehad655.1472/7392110

Conclusions
In patients with ACS treated with PCI, ticagrelor is associated with significantly more repeat coronary revascularizations compared to prasugrel after 12 months, predominantly in remote coronary vessels.

However this was a post hoc study ...but gives the general idea

Note

Funding Acknowledgements: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): German Center for Cardiovascular Research (DZHK),

Kiwi